좌약 포장 시장 : 재료별, 용도별, 지역별 - 예측(-2029년)

The suppository packaging market is projected to reach USD 428 million by 2029, at a CAGR of 6.5% from USD 312 million in 2024. The demand for suppository packaging arises from their versatile applications and advantageous properties across various industries. These polymers, produced through emulsion polymerization, consist of polymer particles dispersed in water. Additionally, suppository packaging find extensive use in textiles for enhancing fabric strength, flexibility, and resistance to washing. In the paper industry, they improve coating properties, printability, and surface finish. Moreover, suppository packaging are utilized in carpet backing, nonwoven fabrics, and specialty latex products, further expanding their application scope. As industries continue to seek cost-effective and environmentally friendly solutions, the demand for suppository packaging is expected to grow. Their low volatile organic compound (VOC) emissions and compliance with stringent environmental regulations make them increasingly attractive.

"Based on material, aluminum/PE is expected to be the fastest growing market during the forecast period, in terms of value."

Aluminum/PE is the fastest growing segments in the suppository packaging market due to their unique combination of properties and diverse applications. The aluminum part gives a remarkable obstruction to dampness, light, and oxygen, which assists with safeguarding the solidarity and viability of the suppository substance. Maintaining the quality and performance of temperature-sensitive medicines over time is crucial, and the aluminum layer plays a key role in extending product shelf life. A packing material that is both pleasantly flexible and durable is created when polyethylene and tailored aluminum film are combined. It ensures that the product remains whole and ready for use as intended by allowing customers to tear open the packaging without damaging the suppository itself.

"Based on application, urethral is the fastest growing market during the forecast period, in terms of value."

The urethral application is the fastest-growing segment in the suppository packaging market. In particular, the benefits associated with urethral drug delivery for diseases like erectile dysfunction and urinary tract infection, in which local treatment could help rapidly to offer relief and improve patient outcome, have been realized more and more. This mode of administration allows for a direct absorption via the mucous membranes and avoids the gastrointestinal tract and first-pass metabolism, which enhances the drug effectiveness. Moreover, the increasing number of conditions requiring the treatment of urinary tract infections, as well as the growing population, is driving demand for these specialty medications as healthcare providers seek more effective treatments for patients who may find it difficult for oral medications, liquid tablets are gaining traction as viable options.

"Based on region, Asia Pacific is the fastest growing market for suppository packaging in 2023, in terms of value."

The demand for suppository packaging in Asia-Pacific is driven by several key factors. With the expansion of healthcare in this sector, hospitals, clinics and pharmaceuticals, the need for specialized drug delivery systems including suppositories increases. The increasing incidence of cancer, diabetes and gastrointestinal disorders requires new methods of drug delivery to the elderly population. As older adults typically implants are preferred or needed because of difficulty in swallowing implants or the need for local treatment. Furthermore, increased health literacy and implants acknowledging the efficacy of treatment drives the growth of the suppository packaging market in the region.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

• By Company Type: Tier 1 - 35%, Tier 2 - 45%, and Tier 3 - 20%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 30%, Europe - 20%, Asia Pacific - 40%, Middle East & Africa-5%, and Latin America-5%

The key players in this market are NextPharma Technologies (UK), CordenPharma (Switzerland), Recipharm AB (Sweden), Valmatic S.R.L. (Italy), Sarong S.p.A. (Italy), Key International (US), HySum Europe GmbH (Germany), FAMAR Health Care Services (Greece), Hudi Pharma HQ (Italy), Adragos Pharma (Germany), LGM Pharma (US), Aluberg s.p.a. (Italy), Delpharm (France), Unither (France), and Trefoil Packaging Pvt Ltd (India).

Research Coverage

This report segments the suppository packaging market based on material, application, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the suppository packaging market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the suppository packaging market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (growing geriatric population, increasing demand for child-resistant packaging, increased focus on patient convenience, rising prevalence of chronic diseases), restraints (adhering to regulatory standards, growing development in technologies), opportunities (growing demand for sustainable and environmentally friendly packaging solutions, rising awareness of health and safety) and challenges (storage and handling requirements).
• Market Penetration: Comprehensive information on the suppository packaging market offered by top players in the global suppository packaging market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the suppository packaging market.
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for suppository packaging market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global suppository packaging market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the suppository packaging market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 LIMITATIONS
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
• 2.3 DATA TRIANGULATION
• 2.4 FACTOR ANALYSIS
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUPPOSITORY PACKAGING MARKET
• 4.2 SUPPOSITORY PACKAGING MARKET, BY MATERIAL
• 4.3 SUPPOSITORY PACKAGING MARKET, BY APPLICATION
• 4.4 NORTH AMERICA: SUPPOSITORY PACKAGING MARKET, BY MATERIAL AND COUNTRY
• 4.5 SUPPOSITORY PACKAGING MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Global increase in aging population and incidence of chronic diseases
    • 5.2.1.2 Rise in healthcare expenditure
    • 5.2.1.3 Rising recognition of suppository benefits
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Rigorous regulatory compliance
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Ongoing technological developments
    • 5.2.3.2 Increasing demand from emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High cost of advanced packaging solutions
    • 5.2.4.2 Limited shelf life

6 INDUSTRY TRENDS

• 6.1 PORTER'S FIVE FORCES ANALYSIS
  • 6.1.1 BARGAINING POWER OF SUPPLIERS
  • 6.1.2 BARGAINING POWER OF BUYERS
  • 6.1.3 INTENSITY OF COMPETITIVE RIVALRY
  • 6.1.4 THREAT OF NEW ENTRANTS
  • 6.1.5 THREAT OF SUBSTITUTES
• 6.2 KEY STAKEHOLDERS & BUYING CRITERIA
  • 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.2.2 BUYING CRITERIA
• 6.3 VALUE CHAIN ANALYSIS
• 6.4 ECOSYSTEM ANALYSIS
• 6.5 TRADE ANALYSIS
  • 6.5.1 EXPORT SCENARIO OF SUPPOSITORY PACKAGING
  • 6.5.2 IMPORT SCENARIO OF SUPPOSITORY PACKAGING
• 6.6 TECHNOLOGY ANALYSIS
  • 6.6.1 KEY TECHNOLOGIES
    • 6.6.1.1 Blister packaging technology
    • 6.6.1.2 Strip packaging technology
    • 6.6.1.3 Form-Fill-Seal (FFS) machine technology
    • 6.6.1.4 Injection molding technology
  • 6.6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.6.2.1 Smart packaging technology
    • 6.6.2.2 Cold chain management technology
• 6.7 IMPACT OF GEN AI ON SUPPOSITORY PACKAGING MARKET
• 6.8 REGULATORY LANDSCAPE
  • 6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 6.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.10 PRICING ANALYSIS
  • 6.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL
  • 6.10.2 AVERAGE SELLING PRICE TREND OF SUPPOSITORY PACKAGING, BY REGION
• 6.11 PATENT ANALYSIS
  • 6.11.1 METHODOLOGY
  • 6.11.2 MAJOR PATENTS
• 6.12 KEY CONFERENCES AND EVENTS, 2024-2025
• 6.13 MACROECONOMIC ANALYSIS
  • 6.13.1 INTRODUCTION

7 SUPPOSITORY PACKAGING MARKET, BY MATERIAL

• 7.1 INTRODUCTION
• 7.2 ALUMINUM/PE
  • 7.2.1 EXCELLENT MOISTURE RESISTANCE AND LIGHT-BLOCKING PROPERTIES TO DRIVE DEMAND
• 7.3 PVC/PE
  • 7.3.1 THERMOFORMABLE PROPERTIES AND ABILITY TO PREVENT LEAKAGE OR CONTAMINATION OF SUPPOSITORIES TO FUEL DEMAND
• 7.4 OTHER MATERIALS

8 SUPPOSITORY PACKAGING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PHARMACEUTICALS
  • 8.2.1 GROWING USE TO ENSURE SAFE, EFFECTIVE, AND INFORMED DELIVERY OF SUPPOSITORY MEDICATIONS TO PATIENTS TO DRIVE MARKET
  • 8.2.2 NASAL SUPPOSITORY PACKAGING
  • 8.2.3 EAR SUPPOSITORY PACKAGING
  • 8.2.4 RECTAL SUPPOSITORY PACKAGING
  • 8.2.5 URETHRAL SUPPOSITORY PACKAGING
  • 8.2.6 VAGINAL SUPPOSITORY PACKAGING
  • 8.2.7 OTHER APPLICATIONS

9 SUPPOSITORY PACKAGING MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
    • 9.2.1.1 Increasing number of pediatric patients to drive market
  • 9.2.2 CANADA
    • 9.2.2.1 Government-led initiatives to promote safe drug packaging to fuel demand
  • 9.2.3 MEXICO
    • 9.2.3.1 Strategic shift of global pharmaceutical companies toward Mexico to drive market
• 9.3 EUROPE
  • 9.3.1 GERMANY
    • 9.3.1.1 Rising emphasis on prevention and self-medication to drive market
  • 9.3.2 FRANCE
    • 9.3.2.1 Increasing healthcare expenditure and health consciousness to drive market
  • 9.3.3 UK
    • 9.3.3.1 Rising focus on patient-centric care to drive market
  • 9.3.4 ITALY
    • 9.3.4.1 Technological advancements in pharmaceutical manufacturing processes to drive market
  • 9.3.5 SPAIN
    • 9.3.5.1 Increasing demand for minimally invasive drug delivery systems to drive market
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
    • 9.4.1.1 Rapidly aging population and increasing healthcare expenditures to drive market
  • 9.4.2 INDIA
    • 9.4.2.1 Expanding pharmaceutical industry to drive market
  • 9.4.3 JAPAN
    • 9.4.3.1 Need for convenient and reliable pharmaceutical packaging solutions to drive market
  • 9.4.4 AUSTRALIA
    • 9.4.4.1 Government-led initiative for safe pharmaceutical drugs production and consumption to drive market
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
    • 9.5.1.1 High adoption in pharmaceutical industry to drive market
  • 9.5.2 ARGENTINA
    • 9.5.2.1 Trend of enhancing packaging technologies to fuel market growth
  • 9.5.3 REST OF SOUTH AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GCC COUNTRIES
    • 9.6.1.1 Saudi Arabia
      • 9.6.1.1.1 Rapidly expanding population and increased investments by foreign companies in pharmaceutical industry to drive market
    • 9.6.1.2 UAE
      • 9.6.1.2.1 Increasing demand for high-value pharmaceutical products to drive market
  • 9.6.2 REST OF GCC COUNTRIES
  • 9.6.3 TURKEY
    • 9.6.3.1 Advantages of suppository packaging over traditional oral medications to drive demand
  • 9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
  • 10.1.1 KEY STRATEGIES/RIGHT TO WIN, 2022-2024
  • 10.1.2 REVENUE ANALYSIS, 2018-2023
  • 10.1.3 MARKET SHARE ANALYSIS, 2023
  • 10.1.4 INDUSTRY STRUCTURE
    • 10.1.4.1 CordenPharma
    • 10.1.4.2 HySum Europe GmbH
    • 10.1.4.3 ACG
    • 10.1.4.4 KAA Timex LR
    • 10.1.4.5 Aluberg S.P.A.
  • 10.1.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.1.6 BRAND/PRODUCT COMPARISON
• 10.2 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.2.1 STARS
  • 10.2.2 EMERGING LEADERS
  • 10.2.3 PERVASIVE PLAYERS
  • 10.2.4 PARTICIPANTS
  • 10.2.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.2.5.1 Company footprint
    • 10.2.5.2 Material footprint
    • 10.2.5.3 Application footprint
    • 10.2.5.4 Region footprint
• 10.3 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.3.1 PROGRESSIVE COMPANIES
  • 10.3.2 RESPONSIVE COMPANIES
  • 10.3.3 DYNAMIC COMPANIES
  • 10.3.4 STARTING BLOCKS
  • 10.3.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.3.5.1 List of key startups/SMEs
    • 10.3.5.2 Competitive benchmarking of key startups/SMEs
• 10.4 COMPETITIVE SCENARIO
  • 10.4.1 DEALS
  • 10.4.2 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 CONSTANTIA FLEXIBLES
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Solutions/Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths/Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses/Competitive threats
  • 11.1.2 DELPHARM
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Solutions/Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths/Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses/Competitive threats
  • 11.1.3 CORDENPHARMA
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Solutions/Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths/Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses/Competitive threats
  • 11.1.4 AENOVA GROUP
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Solutions/Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths/Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses/Competitive threats
  • 11.1.5 UNITHER PHARMACEUTICAL
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Solutions/Services offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Key strengths/Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses/Competitive threats
  • 11.1.6 ACG
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Solutions/Services offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
    • 11.1.6.4 MnM view
  • 11.1.7 HYSUM EUROPE GMBH
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Solutions/Services offered
    • 11.1.7.3 MnM view
  • 11.1.8 CAPRIHANS INDIA LIMITED.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Solutions/Services offered
    • 11.1.8.3 MnM view
  • 11.1.9 FENGCHEN GROUP CO., LTD
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Solutions/Services offered
    • 11.1.9.3 MnM view
  • 11.1.10 KAA TIMEX LR
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Solutions/Services offered
    • 11.1.10.3 MnM view
• 11.2 OTHER PLAYERS
  • 11.2.1 ALUBERG S.P.A.
  • 11.2.2 FAMAR HEALTH CARE SERVICES
  • 11.2.3 LGM PHARMA.
  • 11.2.4 SARONG S.P.A.
  • 11.2.5 ADRAGOS PHARMA.
  • 11.2.6 VALMATIC S.R.L.
  • 11.2.7 HUDI PHARMA
  • 11.2.8 NEXTPHARMA TECHNOLOGIES
  • 11.2.9 TREFOIL PACKAGING PVT LTD
  • 11.2.10 SGM INDIA
  • 11.2.11 GREEN PACK FOILS PVT. LTD.
  • 11.2.12 BERKO PHARMACEUTICALS

12 ADJACENT AND RELATED MARKET

• 12.1 INTRODUCTION
• 12.2 LIMITATIONS
  • 12.2.1 PHARMACEUTICAL PACKAGING MARKET
    • 12.2.1.1 Market definition
    • 12.2.1.2 Pharmaceutical packaging market, by packaging type
    • 12.2.1.3 Pharmaceutical packaging market, by raw material
    • 12.2.1.4 Pharmaceutical packaging market, by drug delivery
    • 12.2.1.5 Pharmaceutical packaging market, by type
    • 12.2.1.6 Pharmaceutical packaging market, by region
  • 12.2.2 HEALTH AND HYGIENE PACKAGING MARKET
    • 12.2.2.1 Market definition
    • 12.2.2.2 Health and hygiene packaging market, by type
    • 12.2.2.3 Health and hygiene packaging market, by form
    • 12.2.2.4 Health and hygiene packaging market, by shipping form
    • 12.2.2.5 Health and hygiene packaging market, by structure
    • 12.2.2.6 Health and hygiene packaging market, by distribution channel
    • 12.2.2.7 Health and hygiene packaging market, by end-use industry
    • 12.2.2.8 Health and hygiene packaging market, by region

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS